share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-10% Owner LILLY ENDOWMENT INC

禮來 | 4：持股變動聲明-股東 LILLY ENDOWMENT INC
美股sec公告 ·  06/12 04:03
牛牛AI助理已提取核心訊息
LILLY ENDOWMENT INC, a reporting entity associated with Eli Lilly and Co (LLY), completed a significant sale of Eli Lilly's common stock on June 10, 2024. The transactions were executed in the open market, with a total of 75,510 shares sold. Prices per share ranged from $851.688 to $870.13, resulting in an aggregate market value of approximately $64,997,274. Following the sales, LILLY ENDOWMENT INC's direct holdings in Eli Lilly amounted to 97,793,810 shares of common stock. The sales occurred in a single day, indicating a substantial change in the endowment's investment in the pharmaceutical company.
LILLY ENDOWMENT INC, a reporting entity associated with Eli Lilly and Co (LLY), completed a significant sale of Eli Lilly's common stock on June 10, 2024. The transactions were executed in the open market, with a total of 75,510 shares sold. Prices per share ranged from $851.688 to $870.13, resulting in an aggregate market value of approximately $64,997,274. Following the sales, LILLY ENDOWMENT INC's direct holdings in Eli Lilly amounted to 97,793,810 shares of common stock. The sales occurred in a single day, indicating a substantial change in the endowment's investment in the pharmaceutical company.
禮來公司關聯的報告實體LILLY ENDOWMENT INC於2024年6月10日完成了一筆重要的禮來股票出售。這些交易在公開市場上執行，共售出75510股。每股價格在851.688至870.13美元之間，導致市值總額約爲6,499,7274美元。在出售後，LILLY ENDOWMENT INC在禮來藥品方面的直接持股爲97,793,810股普通股。這些銷售發生在一天之內，表明這家捐贈基金對這家藥品公司投資的重大變化。
禮來公司關聯的報告實體LILLY ENDOWMENT INC於2024年6月10日完成了一筆重要的禮來股票出售。這些交易在公開市場上執行，共售出75510股。每股價格在851.688至870.13美元之間，導致市值總額約爲6,499,7274美元。在出售後，LILLY ENDOWMENT INC在禮來藥品方面的直接持股爲97,793,810股普通股。這些銷售發生在一天之內，表明這家捐贈基金對這家藥品公司投資的重大變化。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。